4 Analysts Assess Enanta Pharma: What You Need To Know
4 Analysts Assess Enanta Pharma: What You Need To Know
4位分析師評估Enanta Pharma：您需要了解的內容
An in-depth analysis of...In the last three months, 4 analysts have published ratings on Enanta Pharma (NASDAQ:ENTA), offering a diverse range of perspectives from bullish to bearish.
在過去三個月裏，4位分析師對Enanta Pharma（納斯達克：ENTA）進行了評級，提供了從看好到看淡的多元化觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $23.0, along with a high estimate of $27.00 and a low estimate of $21.00. This current average represents a 1.08% decrease from the previous average price target of $23.25.
分析師提供了更深入的見解，已確定了12個月的目標價位，顯示了平均目標爲$23.0，最高估價爲$27.00，最低估價爲$21.00。當前的平均值相比於之前的$23.25的平均目標價位下降了1.08%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀：深入分析
An in-depth analysis of...
最近分析師...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間